Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Im Il Na
Observed names:
Im Na,
Im il Na,
Im-Il Na,
ImIl Na,
Im‐Il Na,
Na, Im Il
show all 6
Institution:
Korea Institute of Radiological and Medical Sciences
Observed institutions:
Seoul National University,
Korea University,
Seoul National University Hospital,
Korea Institute of Radiological and Medical Sciences
ORCID:
0000-0002-3872-6179
Observed ORCID:
0000-0002-3872-6179
OpenAlex ID:
A5004650244
EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
2014
·
Dong-Yeop Shin
, Im Il Na
, et al.
·
Journal of Thoracic Oncology
·
343
PDF
Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line
2008
·
Jin Kyung Rho
, Yun Jung Choi
, et al.
·
Lung Cancer
·
230
18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
2009
·
Im Il Na
, Byung Hyun Byun
, et al.
·
Lung Cancer
·
78
The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
2009
·
Jin Kyung Rho
, Yun Jung Choi
, et al.
·
Molecular Cancer Research
·
61
PDF
Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer
2010
·
Yoon Hee Choi
, Jin Kyung Lee
, et al.
·
Journal of Thoracic Oncology
·
48
18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non–Small Cell Lung Cancer
2008
·
Im Il Na
, Byung Hyun Byun
, et al.
·
Clinical Cancer Research
·
43
Primary Gastric Choriocarcinoma: Two Case Reports and Review of the Literatures
2008
·
Jung Ho Yoon
, Min Soo Kim
, et al.
·
Cancer Research and Treatment
·
29
PDF
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
2007
·
Keun-Wook Lee
, Jee Hyun Kim
, et al.
·
Journal of Korean Medical Science
·
28
Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia
2006
·
Yeon Hee Park
, Won Seog Kim
, et al.
·
Annals of Hematology
·
28
Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy‐naive patients with extensive‐disease small cell lung cancer
2009
·
Dae Ho Lee
, Sang‐We Kim
, et al.
·
Cancer
·
25
A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer
2008
·
Im Il Na
, Tae Hyun Lee
, et al.
·
European Journal of Cancer
·
25
Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer
2014
·
Soyeun Kim
, Youngjin Ko
, et al.
·
Psycho-Oncology
·
24
Evaluation of Adrenal Masses in Lung Cancer Patients Using F-18 FDG PET/CT
2010
·
A. Ra Cho
, Ilhan Lim
, et al.
·
Nuclear Medicine and Molecular Imaging
·
24
PDF
Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP
2015
·
Dong-Yeop Shin
, Areumnuri Kim
, et al.
·
Annals of Hematology
·
20
Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis
2017
·
Hye-Ryoun Kim
, Seo Yun Kim
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
18
Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer
2005
·
Keun-Wook Lee
, Seock-Ah Im
, et al.
·
Japanese Journal of Clinical Oncology
·
17
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
2018
·
Seo Yun Kim
, Jae Kyung Myung
, et al.
·
Tuberculosis & respiratory diseases
·
14
PDF
The Effect of Acquired Cisplatin Resistance on Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells
2011
·
Jin Kyung Rho
, Yun Jung Choi
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
·
14
High incidence of mucosa-associated lymphoid tissue in primary thyroid lymphoma: A clinicopathologic study of 18 casesin the Korean population
2006
·
Jang Hyun Cho
, Yeon Hee Park
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
14
Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer
2011
·
Im Il Na
, Jong Heon Park
, et al.
·
ISRN Oncology
·
13
PDF
Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study
2008
·
Byung Hyun Byun
, Im Il Na
, et al.
·
Annals of Nuclear Medicine
·
13
Clinical significance of 18F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: A retrospective study
2007
·
Im Il Na
, Gi Jeong Cheon
, et al.
·
Lung Cancer
·
12
Primary gastric lymphoma of T-cell origin: Clinicopathologic features and treatment outcome
2006
·
Yeon Hee Park
, Won Seog Kim
, et al.
·
Leukemia Research
·
11
A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site
2015
·
Dong-Yeop Shin
, Yoon Hee Choi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
8
Art Therapy in Patients with Terminal Cancer and Their Families: A Multiple Case Study
2023
·
Nahyun Park
, Im-Il Na
, et al.
·
The Journal of Hospice and Palliative Care
·
7
PDF
Show more works
View as search
Works count:
56
Citation count:
1,207
H-index:
16
I10-index:
23
Year
Topic
Type